Chief Development Officer · Trevi Therapeutics, Inc. (TRVI)

James Cassella

A named executive officer of Trevi Therapeutics in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,637,220

FY2024: $1,441,119

Compensation figures as of the proxy filed April 21, 2026 (DEF 14A).

James Cassella compensation by year

Trevi Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Trevi Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$120,000$488,270
Bonus$53,666$196,000
Stock awards$0$0
Option awards$1,161,707$942,450
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$105,746$10,500
Total$1,441,119$1,637,220

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Trevi Therapeutics, Inc. DEF 14A filed April 21, 2026, accession 0001193125-26-166695, and prior-year filings. Open the filing on EDGAR.

$1.4M
$1.6M
FY24
FY25
SalaryBonusOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option275,000—$3.34
Option257,500—$4.22

Per the Outstanding Equity Awards at Fiscal Year-End table in Trevi Therapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Trevi Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Jennifer GoodPresident and Chief Executive Officer$3,944,892
James Cassella · this pageChief Development Officer$1,637,220
Farrell SimonChief Commercial Officer$1,355,897

The full Trevi Therapeutics compensation record

free company brief

This page is one person within Trevi Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Trevi Therapeutics's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Trevi Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy